Wang Zongqi, Chen Gang
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, Jiangsu Province 215006, China; Institute of Stroke Research, Soochow University, Suzhou, Jiangsu Province 215006, China.
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, Jiangsu Province 215006, China; Institute of Stroke Research, Soochow University, Suzhou, Jiangsu Province 215006, China.
Neurobiol Dis. 2023 Apr;179:106060. doi: 10.1016/j.nbd.2023.106060. Epub 2023 Mar 5.
Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Survivors may experience movement disorders, memory loss, and cognitive deficits. However, there is a lack of understanding of the pathophysiology of TBI-mediated neuroinflammation and neurodegeneration. The immune regulation process of TBI involves changes in the peripheral and central nervous system (CNS) immunity, and intracranial blood vessels are essential communication centers. The neurovascular unit (NVU) is responsible for coupling blood flow with brain activity, and comprises endothelial cells, pericytes, astrocyte end-feet, and vast regulatory nerve terminals. A stable NVU is the basis for normal brain function. The concept of the NVU emphasizes that cell-cell interactions between different types of cells are essential for maintaining brain homeostasis. Previous studies have explored the effects of immune system changes after TBI. The NVU can help us further understand the immune regulation process. Herein, we enumerate the paradoxes of primary immune activation and chronic immunosuppression. We describe the changes in immune cells, cytokines/chemokines, and neuroinflammation after TBI. The post-immunomodulatory changes in NVU components are discussed, and research exploring immune changes in the NVU pattern is also described. Finally, we summarize immune regulation therapies and drugs after TBI. Therapies and drugs that focus on immune regulation have shown great potential for neuroprotection. These findings will help us further understand the pathological processes after TBI.
创伤性脑损伤(TBI)是全球范围内死亡和残疾的主要原因。幸存者可能会出现运动障碍、记忆力丧失和认知缺陷。然而,人们对TBI介导的神经炎症和神经退行性变的病理生理学缺乏了解。TBI的免疫调节过程涉及外周和中枢神经系统(CNS)免疫的变化,颅内血管是重要的通讯中心。神经血管单元(NVU)负责将血流与脑活动耦合,由内皮细胞、周细胞、星形胶质细胞终足和大量调节性神经末梢组成。稳定的NVU是正常脑功能的基础。NVU的概念强调不同类型细胞之间的细胞间相互作用对于维持脑内环境稳定至关重要。先前的研究探讨了TBI后免疫系统变化的影响。NVU可以帮助我们进一步了解免疫调节过程。在此,我们列举了原发性免疫激活和慢性免疫抑制的矛盾之处。我们描述了TBI后免疫细胞、细胞因子/趋化因子和神经炎症的变化。讨论了NVU成分的免疫调节后变化,并描述了探索NVU模式中免疫变化的研究。最后,我们总结了TBI后的免疫调节疗法和药物。专注于免疫调节的疗法和药物已显示出巨大的神经保护潜力。这些发现将有助于我们进一步了解TBI后的病理过程。